Medicina
Departamento
University of Genoa
Génova, ItaliaPublicaciones en colaboración con investigadores/as de University of Genoa (61)
2024
-
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
The Lancet Infectious Diseases, Vol. 24, Núm. 1, pp. e59-e68
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
-
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study
Mycoses, Vol. 67, Núm. 1
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 24, Núm. 1, pp. 77-90
-
Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)
Nature Reviews Cardiology
-
Impact of acute and persistent stent malapposition after percutaneous coronary intervention on adverse cardiovascular outcomes
Minerva cardiology and angiology, Vol. 71, Núm. 5, pp. 525-534
-
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
Critical Care, Vol. 27, Núm. 1
-
Spatial predictors of immunotherapy response in triple-negative breast cancer
Nature, Vol. 621, Núm. 7980, pp. 868-876
2022
-
Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review
Mycoses, Vol. 65, Núm. 3, pp. 362-373
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268
-
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
Annals of Oncology, Vol. 33, Núm. 5, pp. 534-543
-
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis
Mycoses, Vol. 65, Núm. 12, pp. 1073-1111
-
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data
Journal of Infection
-
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Clinical Microbiology and Infection, Vol. 28, Núm. 4, pp. 580-587
2021
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
-
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
Intensive Care Medicine
-
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in Aurora, the breast international group (Big) molecular screening initiative
Cancer Discovery, Vol. 11, Núm. 11, pp. 2796-2811
-
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
Neurology, Vol. 96, Núm. 2, pp. e214-e227
2020
-
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
Clinical Microbiology and Infection, Vol. 26, Núm. 8, pp. 1024-1033